Advanced Biomed Common Stock Market Value
| ADVB Stock | 0.24 0.01 4.00% |
| Symbol | Advanced |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Advanced Biomed assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Advanced Biomed Common requires distinguishing between market price and book value, where the latter reflects Advanced's accounting equity. The concept of intrinsic value - what Advanced Biomed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Advanced Biomed's price substantially above or below its fundamental value.
Understanding that Advanced Biomed's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Advanced Biomed represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Advanced Biomed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Advanced Biomed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Advanced Biomed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Advanced Biomed.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Advanced Biomed on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Advanced Biomed Common or generate 0.0% return on investment in Advanced Biomed over 90 days. Advanced Biomed is related to or competes with BioNexus Gene, Trinity Biotech, Ridgetech, Aptorum Group, Beyond Air, Marker Therapeutics, and Mustang Bio. Advanced Biomed is entity of United States More
Advanced Biomed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Advanced Biomed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Advanced Biomed Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 28.22 | |||
| Value At Risk | (9.68) | |||
| Potential Upside | 8.11 |
Advanced Biomed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Advanced Biomed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Advanced Biomed's standard deviation. In reality, there are many statistical measures that can use Advanced Biomed historical prices to predict the future Advanced Biomed's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.54) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Advanced Biomed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Advanced Biomed February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.53) | |||
| Mean Deviation | 4.0 | |||
| Coefficient Of Variation | (815.75) | |||
| Standard Deviation | 5.41 | |||
| Variance | 29.23 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.54) | |||
| Maximum Drawdown | 28.22 | |||
| Value At Risk | (9.68) | |||
| Potential Upside | 8.11 | |||
| Skewness | 0.0464 | |||
| Kurtosis | 0.8275 |
Advanced Biomed Common Backtested Returns
Advanced Biomed Common secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Advanced Biomed Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Advanced Biomed's Standard Deviation of 5.41, mean deviation of 4.0, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.24, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Advanced Biomed will likely underperform. At this point, Advanced Biomed Common has a negative expected return of -0.74%. Please make sure to confirm Advanced Biomed's potential upside and the relationship between the accumulation distribution and price action indicator , to decide if Advanced Biomed Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.68 |
Good predictability
Advanced Biomed Common has good predictability. Overlapping area represents the amount of predictability between Advanced Biomed time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Advanced Biomed Common price movement. The serial correlation of 0.68 indicates that around 68.0% of current Advanced Biomed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:Check out Advanced Biomed Correlation, Advanced Biomed Volatility and Advanced Biomed Performance module to complement your research on Advanced Biomed. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Advanced Biomed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.